HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolonged neutral endopeptidase inhibition in heart failure.

Abstract
We studied the hormonal, renal and hemodynamic effects of prolonged treatment with SCH 39370, a new neutral endopeptidase (NEP) inhibitor, in experimental congestive heart failure (CHF). Coronary-ligated CHF rats and sham-operated controls received vehicle or SCH 39370 30 mg/kg s.c. twice daily for six days. In rats with heart failure, SCH 39370 elevated the high plasma atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) levels 2-fold both initially and at the end of the experiment. Initially, water balance was more negative in SCH 39370-treated CHF rats than in those treated with vehicle. In all SCH 39370-treated rats, ANP, cGMP and electrolyte excretion and diuresis were pronounced for 6 h after injection but attenuated thereafter. Blood pressure and pulse remained unchanged. On reverse phase high performance liquid chromatography (HPLC), ANP-(99-126) appeared to be the only circulating form of ANP in rats with heart failure. Three forms have been discovered in patients with heart failure. HPLC revealed only intact ANP in plasma of rats with heart failure during SCH 39370 treatment. NEP inhibitors may provide a new tool for treating chronic heart failure.
AuthorsK Helin, I Tikkanen, T Tikkanen, O Saijonmaa, E J Sybertz, S Vemulapalli, H Sariola, F Fyhrquist
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 198 Issue 1 Pg. 23-30 (May 30 1991) ISSN: 0014-2999 [Print] Netherlands
PMID1655477 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dipeptides
  • Protease Inhibitors
  • Sch 39370
  • Atrial Natriuretic Factor
  • Endopeptidases
  • Renin
  • Metalloendopeptidases
  • Cyclic GMP
Topics
  • Animals
  • Atrial Natriuretic Factor (blood)
  • Blood Pressure (drug effects)
  • Body Weight (drug effects)
  • Chromatography, High Pressure Liquid
  • Cyclic GMP (blood, urine)
  • Dipeptides (therapeutic use)
  • Endopeptidases (metabolism)
  • Heart Failure (drug therapy, physiopathology)
  • Hemodynamics (drug effects)
  • Kidney (drug effects)
  • Kidney Function Tests
  • Male
  • Metalloendopeptidases (antagonists & inhibitors)
  • Protease Inhibitors (pharmacology)
  • Pulse (drug effects)
  • Rats
  • Rats, Inbred Strains
  • Renin (blood)
  • Water-Electrolyte Balance (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: